Share:
Peer-Reviewed Publication
Bioact Mater2026;661115-1132.December 1, 2026Journal Article

Single-cell transcriptome-guided biomimetic magnetothermal hydrogel microspheres for multimodal eradication of residual glioblastoma.

Nan Wu1,2, Xi Luan2, Bihe Yuan3, Mingyuan Xia4, Jianliang Shen2, Jing Lin2,5, Lixia Xu1,6, Hai Lin2, Lexiang Zhang2,5,7, Fangfu Ye2,8, Hua Yan1,6,9
1Department of Neurosurgery, Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, Tianjin, 300070, PR China.
2Zhejiang Key Laboratory of Soft Matter Biomedical Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325000, PR China.
3School of Physical Sciences, University of Science and Technology of China, Hefei, Anhui, 230026, PR China.
4School of Materials Science and Engineering, Central South University, Changsha, Hunan, 410083, PR China.
5Department of Obstetrics and Gynecology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, PR China.
6Tianjin Key Laboratory of Cerebral Blood Flow Reconstruction and Head and Neck Tumor New Technology Translation, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, 300350, PR China.
7Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, PR China.
8Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, 100190, PR China.
9Tianjin Fourth Central Hospital, The Affiliated Hospital of Tianjin Medical University, Tianjin, 300140, PR China.

Abstract

Incomplete resection and rapid postoperative recurrence remain major challenges in glioblastoma (GBM) treatment. Inspired by the self-healing microduct architecture of pine resin, we developed an injectable magnetothermal-responsive hierarchical hydrogel microsphere platform, HGM + Multi(+), for spatiotemporally programmed magnetothermal ablation, anti-angiogenic blockade, and targeted chemotherap…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.